At least they seem to know what they're up against, though:
“Type 1 diabetics are a pretty skeptical audience,” says Faustman. “There’s been a lot of disappointment [from other research].”Ha! You don't say? Maybe we're tired of the media crying wolf every other year.
In any case, the vaccine is moving into the next stage of testing, so we'll see what comes of it.